To the Editor: Chronic kidney disease‐mineral bone disorder (CKD‐MBD) has been found universally in hemodialysis (HD) patients. It increases the risk of cardiovascular morbidity and mortality, particularly vascular calcification.[1] Consequently,… Click to show full abstract
To the Editor: Chronic kidney disease‐mineral bone disorder (CKD‐MBD) has been found universally in hemodialysis (HD) patients. It increases the risk of cardiovascular morbidity and mortality, particularly vascular calcification.[1] Consequently, it is crucial to effectively control the biochemical indicators’ abnormalities of CKD‐MBD. International guidelines have provided measures for CKD‐MBD, but relevant research from developing countries is limited, especially in China.[2]
               
Click one of the above tabs to view related content.